Why the Vpatch System

VpatchCardio has developed the “Vkit” a “world first” wearable, 3 lead ECG, cardiac event diagnostic device, comprising ten(10) “on-body” arrhythmia detection algorithms automatically analysing event triggered and patient activated episodes.

The Vkit is connected globally via the mobile cellular network to Vcentral -a secure cloud based platform developed by VpatchCardio.

The Vkit utilises sophisticated analytics that enables Vcentral to create and transmit a diagnostically actionable and interactive report directly to the Health Care Professional in “near” real time.
The Vkit is a low cost and superior solution to traditional cardiac event monitoring devices that significantly shortens diagnosis time and accelerates the implementation of further investigations, interventions or treatment

patch
  • The Vkit monitors continuously using its patented, highly specific and sensitive detection algorithms.
  • The Vki tcan immediately detect the presence of either episodic or continuous supraventricular (including Atrial Fibrillation) and ventricular based arrhythmias.
  • The Vki tis FDA and TGA approved and has CE Mark .
  • The Vkit is Australian manufactured and is now ready to be launched globally. Distributors and potential partners in over 10 countries have expressed significant interest in representing VpatchCardio commencing in 2019
patch1

Why Vpatch Cardio?

1. Commercial and Clinical advantage
2. Lower cost alternative to a Loop Recorder
3. Highly accurate 3 lead design and on board 10 arrhythmia recognition
4. Regulatory clearances completed, FDA, CE Mark and TGA approval
triangle

Med Care Plus: Offers other Diagnostic Test